User profiles for Ling Yin

Ling Yin (尹凌)

- Verified email at siat.ac.cn - Cited by 3136

Ling Yin

- Verified email at mdanderson.org - Cited by 639

A mathematical model for simulating the phase-based transmissibility of a novel coronavirus

…, J Rui, QP Wang, ZY Zhao, JA Cui, L Yin - Infectious diseases of …, 2020 - mednexus.org
Background: As reported by the World Health Organization, a novel coronavirus (2019-nCoV)
was identified as the causative virus of Wuhan pneumonia of unknown etiology by …

[PDF][PDF] Light‐triggered assembly of gold nanoparticles for photothermal therapy and photoacoustic imaging of tumors in vivo

X Cheng, R Sun, L Yin, Z Chai, H Shi… - Advanced …, 2017 - gaomingyuan.com
DOI: 10.1002/adma. 201604894 aggregation of AuNPs at tumorous sites. One of the possible
stimuli is the acidic extracellular pH of solid tumors. A number of pH-sensitive AuNPs that …

COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The World
Health Organization (WHO) therefore endorses supportive care only. However, frontline …

Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 …

…, HX Zhai, J Wang, J Forrester, H Qu, L Yin… - Journal of medicinal …, 2010 - ACS Publications
By incorporating histone deacetylase (HDAC) inhibitory functionality into the pharmacophore
of the epidermal growth factor receptor (EGFR) and human epidermal growth factor …

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Z Zhang, ZX Wang, YX Chen, HX Wu, L Yin, Q Zhao… - Genome Medicine, 2022 - Springer
Background Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in
cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the …

Elimination of preoperative testing in ambulatory surgery

F Chung, H Yuan, L Yin, S Vairavanathan… - Anesthesia & …, 2009 - journals.lww.com
BACKGROUND: Preoperative testing has been criticized as having little impact on perioperative
outcomes. We conducted a randomized, single-blind, prospective, controlled pilot study …

CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer …

…, XU Tao, J Wang, R Atoyan, H Qu, DG Wang, L Yin… - Cancer research, 2010 - AACR
Receptor tyrosine kinase inhibitors have recently become important therapeutics for a
variety of cancers. However, due to the heterogeneous and dynamic nature of tumors, the …

Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and phosphatidylinositol 3-kinase signaling

…, DG Wang, J Wang, GX Xu, R Atoyan, H Qu, L Yin… - Clinical cancer …, 2012 - AACR
Purpose: Given that histone deacetylase (HDAC) inhibitors are known to induce multiple
epigenetic modifications affecting signaling networks and act synergistically with …

Viral community-wide auxiliary metabolic genes differ by lifestyles, habitats, and hosts

XQ Luo, P Wang, JL Li, M Ahmad, L Duan, LZ Yin… - Microbiome, 2022 - Springer
Background Viral-encoded auxiliary metabolic genes (AMGs) are important toolkits for
modulating their hosts’ metabolisms and the microbial-driven biogeochemical cycles. Although …

Notch signaling: emerging molecular targets for cancer therapy

L Yin, OC Velazquez, ZJ Liu - Biochemical pharmacology, 2010 - Elsevier
The Notch signaling pathway is a highly conserved developmental pathway, which plays a
critical role in cell-fate decision, tissue patterning and morphogenesis. There is increasing …